These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 2576349)
1. Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Efferth T; Löhrke H; Volm M Anticancer Res; 1989; 9(6):1633-7. PubMed ID: 2576349 [TBL] [Abstract][Full Text] [Related]
2. Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line. Duensing S; Brevis Nunez F; Meyer N; Anastassiou G; Nasarek A; Grosse J; Buer J; Probst M; Ganser A; Alzpodien J Invasion Metastasis; 1996; 16(2):65-72. PubMed ID: 9030241 [TBL] [Abstract][Full Text] [Related]
3. Expression of protein kinase C in human renal cell carcinoma cells with inherent resistance to doxorubicin. Efferth T; Volm M Anticancer Res; 1992; 12(6B):2209-11. PubMed ID: 1363517 [TBL] [Abstract][Full Text] [Related]
4. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells? Denis-Gay M; Petit JM; Ratinaud MH Anticancer Res; 1995; 15(1):121-6. PubMed ID: 7733620 [TBL] [Abstract][Full Text] [Related]
5. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas. Volm M; Mattern J; Efferth T; Pommerenke EW Anticancer Res; 1992; 12(4):1063-7. PubMed ID: 1354430 [TBL] [Abstract][Full Text] [Related]
6. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041 [TBL] [Abstract][Full Text] [Related]
7. Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis. Müller MR; Lennartz K; Nowrousian MR; Dux R; Tsuruo T; Rajewsky MF; Seeber S Cytometry; 1994 Jan; 15(1):64-72. PubMed ID: 7512893 [TBL] [Abstract][Full Text] [Related]
8. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors. De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line. Hill AB; Beck WT; Trent JM Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436 [TBL] [Abstract][Full Text] [Related]
10. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells. Nare B; Prichard RK; Georges E Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Scheper RJ; Broxterman HJ; Scheffer GL; Kaaijk P; Dalton WS; van Heijningen TH; van Kalken CK; Slovak ML; de Vries EG; van der Valk P Cancer Res; 1993 Apr; 53(7):1475-9. PubMed ID: 7680954 [TBL] [Abstract][Full Text] [Related]
12. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies. Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068 [TBL] [Abstract][Full Text] [Related]
13. Effects of progesterone and leukotriene receptor antagonists in experimental models of P-glycoprotein-related resistance. Nuessler V; Pelka-Fleischer R; Zwierzina H; Wilmanns W; Denzlinger C Eur J Med Res; 1997 Apr; 2(4):159-64. PubMed ID: 9110922 [TBL] [Abstract][Full Text] [Related]
14. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
15. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Rodins K; Cheale M; Coleman N; Fox SB Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116 [TBL] [Abstract][Full Text] [Related]
16. [Value of rhodamine 123 in the detection of minor amounts of multidrug resistant cells]. Maynadié M; Lizard G; Solary E; Parmeland C; Carli PM Bull Cancer; 1994 May; 81(5):409-13. PubMed ID: 7749218 [TBL] [Abstract][Full Text] [Related]
17. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin. Rappa G; Lorico A; Sartorelli AC Cancer Res; 1993 Nov; 53(22):5487-93. PubMed ID: 8106148 [TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Volm M; Bak M; Efferth T; Lathan B; Mattern J Anticancer Res; 1988; 8(4):531-5. PubMed ID: 2902821 [TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Dalton WS; Cress AE; Alberts DS; Trent JM Cancer Res; 1988 Apr; 48(7):1882-8. PubMed ID: 2894893 [TBL] [Abstract][Full Text] [Related]
20. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]